Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vbi Vaccines Inc CS (NQ: VBIV ) 0.0653 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vbi Vaccines Inc CS < Previous 1 2 3 4 5 6 7 Next > VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial December 02, 2021 VBI Vaccines Inc (NASDAQ: VBIV) has presented updated 12-month and 18-month overall survival (OS) data from the Phase 2a study of VBI-1901, the Company's... Via Benzinga VBI Vaccines to Present New Overall Survival Data from Phase 2a Study in Recurrent GBM at the World Vaccine & Immunotherapy Congress 2021 December 01, 2021 From VBI Vaccines Inc. Via Business Wire BYSI Stock Alert: Bad News From the FDA Has BeyondSpring Tanking Today December 01, 2021 BeyondSpring is falling hard after the FDA turned down a once-promising drug candidate. Here's why you shouldn't write off BYSI stock. Via InvestorPlace Exposures Product Safety Nubank IPO: 12 Things for Potential Investors to Know About the Buffett-Backed Brazilian Fintech December 01, 2021 Nubank is in the news today as investors discuss new details from the fintech company's filing for an initial public offering (IPO). Via InvestorPlace Topics Initial Public Offering Exposures Securities Market OP Stock: 13 Things for OceanPal Investors to Know About the Diana Shipping Spinoff as Shares Soar December 01, 2021 OceanPal (OP) stock is riding higher Wednesday on the wave of its public debut yesterday after a spinoff from Diana Shipping (DSX)! Via InvestorPlace VBIV Stock Is Shooting Higher on Big FDA Vaccine Approval News December 01, 2021 VBI Vaccines just got the green light from the FDA for its new Hepatitis B vaccine. VBIV stock is reacting well so far today. Via InvestorPlace Exposures Product Safety FDA Approves VBI Vaccines' 3-Antigen Hepatitis B Vaccine December 01, 2021 The FDA has approved VBI Vaccines Inc's (NASDAQ: VBIV) PreHevbrio [Hepatitis B Vaccine (Recombinant)] to prevent the infection caused by all known subtypes of... Via Benzinga Exposures Product Safety VBI Vaccines Announces FDA Approval of PreHevbrio™ for the Prevention of Hepatitis B in Adults December 01, 2021 From VBI Vaccines Inc. Via Business Wire The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout November 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-... Via Benzinga Exposures Product Safety The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, & More November 28, 2021 Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant helped mitigate the losses notched earlier in the holiday-shortened week. Via Talk Markets Exposures COVID-19 Product Safety The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week November 28, 2021 Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses... Via Benzinga Exposures COVID-19 Product Safety VBI Vaccines to Participate in Jefferies London Healthcare Conference November 16, 2021 From VBI Vaccines Inc. Via Business Wire The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More November 08, 2021 Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... Via Benzinga VBI Vaccines Announces Third Quarter 2021 Financial Results and Provides Corporate Update November 08, 2021 From VBI Vaccines Inc. Via Business Wire Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates November 02, 2021 The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a... Via Benzinga VBI Vaccines Announces e-Poster Presentation of 3-Antigen Prophylactic Hepatitis B Vaccine Data at The Liver Meeting® 2021 November 01, 2021 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Publication of Results from Pivotal Phase 3 Study, CONSTANT, of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine Candidate in The Journal of the American Medical Association Network Open October 13, 2021 From VBI Vaccines Inc. Via Business Wire VBI Vaccines to Participate in Upcoming Investor Conferences October 04, 2021 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces New Preclinical Data and Initiation of VBI-2905 Clinical Study Targeting Broadened Immunity Against COVID-19 and Variants of Concern September 29, 2021 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Second Quarter 2021 Financial Results and Provides Corporate Update August 02, 2021 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Appoints Linda Bain to Board of Directors July 07, 2021 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Reports New CPT Code Issued for a 3-Antigen Prophylactic Hepatitis B Vaccine July 01, 2021 From VBI Vaccines Inc. Via Business Wire Why Shares of VBI Vaccines Soared, and Then Fell 7%, on Tuesday June 29, 2021 Investors almost seemed ready to take profits once shares hit their highest level since February. Via The Motley Fool Exposures COVID-19 VBI Vaccines Stock Is Trading Higher On Encouraging Data From COVID-19 Vaccine Candidate Trial June 29, 2021 VBI Vaccines Inc (NASDAQ: VBIV) has announced positive Phase 1 data from its Phase 1/2 trial evaluating its enveloped virus-like particle (eVLP) COVID-19 vaccine... Via Benzinga Exposures COVID-19 VBI Vaccines Announces Initial Positive Phase 1 Data for Its eVLP Vaccine Candidate Against COVID-19 June 29, 2021 From VBI Vaccines Inc. Via Business Wire Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021 June 23, 2021 From Brii Biosciences Via Business Wire VBI Vaccines to Present at Upcoming Scientific Conferences June 17, 2021 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Results of Annual General Meeting June 09, 2021 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Multiple Abstracts Accepted for Poster Presentations at EASL 2021 June 09, 2021 From VBI Vaccines Inc. Via Business Wire Why Agenus Stock Is Jumping Today June 08, 2021 There was some positive news, but it probably wasn't a huge catalyst for the stock. Via The Motley Fool Exposures Product Safety < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.